FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On May 26, 2004
Table of Contents
Docket # Title
1975N-0183H Health-Care Antiseptic Drug Products for OTC Human Use
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1997S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection)
1999P-2630 Establish a Daily Value for "added sugars"
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
2002H-0443 Civil Money Penalty Re: LaHaye Ctr.for Advanced Eye Care
2003H-0432 Civil Money Penalty, Korangy Radiology Associates, PA
2003P-0029 Remove metered-dose inhalers (MDI) containing moiety albuter
2004N-0086 Diabetes: Targeting Safe and Effective Prevention and Treatment; Public Meeting
2004P-0128 ANADA for clavamox (amoxicillin trihydrate/clavulanate potassium) tablets for dogs and cats
1975N-0183H Health-Care Antiseptic Drug Products for OTC Human Use
ACK 17 HFA-305 to HY-GENE Biomedical Corporation Vol #: 201
CP 17 HY-GENE Biomedical Corporation Vol #: 201
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 13965 Biotech Corporation Vol #: 119
LET 13966 Biotech Corporation Vol #: 119
LET 13967 Now Foods Vol #: 119
LET 13968 Anabolic Laboratories, Inc. Vol #: 119
LET 13969 Anabolic Laboratories, Inc. Vol #: 119
LET 13970 Anabolic Laboratories, Inc. Vol #: 119
LET 13971 Anabolic Laboraories, Inc. Vol #: 119
LET 13972 Anabolic Laboratories, Inc. Vol #: 119
LET 13973 Anabolic Laboratories, Inc. Vol #: 119
LET 13974 Anabolic Laboratories, Inc. Vol #: 119
LET 13975 Anabolic Laboratories, Inc. Vol #: 119
LET 13976 Anabolic Laboraoties, Inc. Vol #: 119
LET 13977 Anabolic Laboratories, Inc. Vol #: 119
LET 13978 Now Foods Vol #: 119
LET 13979 Perrigo Company of South Carolina Vol #: 119
LET 13980 Integrative Therapeutics Inc. Vol #: 119
LET 13981 Integrative Therapeutics Inc. Vol #: 119
LET 13982 Integrative Therapeutics Inc. Vol #: 119
LET 13983 Botanical Laboratories, Inc. Vol #: 119
LET 13984 Optimum Nutrition Vol #: 119
LET 13985 Enzymatic Therapy Natural Medicines Vol #: 119
LET 13986 Enzymatic Therapy Natural Medicines Vol #: 119
LET 13987 Enzymatic Therapy Natural Medicines Vol #: 119
LET 13988 Enzymatic Therapy Natural Medicines Vol #: 119
LET 13989 Enzymatic Therapy Natural Medicines Vol #: 119
LET 13990 Enzymatic Therapy Nautral Medicines Vol #: 119
LET 13991 Perrigo Company of South Carolina Vol #: 119
LET 13992 Integrative Therapeutics Inc. Vol #: 119
LET 13993 Earthlab, Inc, Vol #: 119
LET 13994 Earthlab, Inc. Vol #: 120
LET 13995 Earthlab, Inc. Vol #: 120
LET 13996 Earthlab, Inc. Vol #: 120
LET 13997 Earthlab, Inc. Vol #: 120
LET 13998 Earthlab, Inc. Vol #: 120
LET 13999 Perrigo Company of South Carolina Vol #: 120
LET 14000 Perrigo Company of South Carolina Vol #: 120
1997S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection)
LET 747 HFS-800 to Kendy USA LLC Vol #: 22
LET 748 HFS-800 to LIFEnhance Inc Vol #: 22
LET 749 HFS-800 to Spirit Sciences USA Inc Vol #: 22
LET 750 HFS-800 to Tianshi Health Products, Inc Vol #: 22
LET 751 HFS-800 to Custom Nutrition Laboratories Vol #: 22
LET 752 HFS-800 to Bios Biochemicals Vol #: 22
1999P-2630 Establish a Daily Value for "added sugars"
EMC 784 Consumer Vol #: 33
EMC 785 Consumer Vol #: 33
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
EMC 773 Wayne Clark Vol #: 271
EMC 774 Richard Lamonica Vol #: 271
EMC 775 Jennifer Haynes Vol #: 271
EMC 776 Margaret Viers Vol #: 271
SF 6 GCF-1 Vol #: 389
2002H-0443 Civil Money Penalty Re: LaHaye Ctr.for Advanced Eye Care
STP 1 GCF-1 Vol #: 1
2003H-0432 Civil Money Penalty, Korangy Radiology Associates, PA
LET 5 GCF-1 Vol #: 2
2003P-0029 Remove metered-dose inhalers (MDI) containing moiety albuter
C 10 Natural Resources Defense Council, NRDC Vol #: 2
C 11 Bespack Inc Vol #: 2
C 12 Natural Resources Defense Council, NRDC Vol #: 2
MM 1 GCF-1 and Barbour Griffith & Rogers Inc, GlaxoSmithKline Vol #: 2
2004N-0086 Diabetes: Targeting Safe and Effective Prevention and Treatment; Public Meeting
C 4 Metabolic Associates LLC Vol #: 1
C 5 Errol B Dendy MD Vol #: 1
C 6 Hope Warshaw Associates Vol #: 1
C 7 University of California, San DIego Vol #: 1
EMC 2 GKL Associates Vol #: 1
EMC 3 Texas Childrens Hospital Vol #: 1
EMC 4 Mitzi Hazard PT CDE Vol #: 1
EMC 5 Jean Rocap RD LD CDE Vol #: 1
EMC 6 University of California San Diego, Veterans Affairs Medical Center Vol #: 1
EMC 7 Scripps Whittier Diabetes Program Vol #: 1
EMC 8 Scripps Whittier Diabetes Institute Vol #: 1
EMC 9 Scripps Whittier Diabetes Program Vol #: 1
EMC 10 consumer Vol #: 1
EMC 11 Rothschild Financial Consulting Vol #: 1
EMC 12 The Diabetes Center at Mercy Medical Center Vol #: 1
2004P-0128 ANADA for clavamox (amoxicillin trihydrate/clavulanate potassium) tablets for dogs and cats
PDN 1 HFV-1 to Smart Drug Systems, Inc Vol #: 1

Page created on May 28, 2004 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management